The controversial drug, called Aduhelm, costs $56,000 a year and some patients could face copayments of $11,500 annually.
  • HuffPost
  • Jun 11, 2021

FDA Adviser Quits Over 'Probably The Worst' Approval Decision Of Alzheimer's Drug - HuffPost

WASHINGTON (AP) A new $56,000-a-year Alzheimers drug would raise Medicare premiums broadly, and some patients who are prescribed the medication could face copayments of about $11,500 annually, accord… [+4728 chars]

More In business